TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

INVATECH

Pharmaceuticals
Generics

INVATECH is a generic drug manufacturer with 3 FDA-approved products.

1982
Since
3
Drugs
-
Trials
154
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
DIVALPROEX SODIUM 2026-01-29
Labeling
DIVALPROEX SODIUM 2026-01-29
Labeling
DIVALPROEX SODIUM 2026-01-28
Labeling
DIVALPROEX SODIUM 2026-01-28
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
DIVALPROEX SODIUM 2026-01-24
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
BUPROPION HYDROCHLORIDE 2025-11-06
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...